Effectiveness, Safety, and Tolerability of Anti-HER2 Drugs as Targeted Therapy for Egyptian Patients With ERBB2-Positive Breast Cancer
Clinical trial NCT07416409 · COMPLETED
Trial details
- NCT number
- NCT07416409
- Sponsor
- Deraya University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-10
- Primary completion
- 2024-06-20
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.